SPRBD |
Spruce Biosciences Inc. |
Common Stock, par value $0.0001 per share |
21.6% |
$1.11M |
|
121K |
|
Ikarian Capital, LLC |
Oct 6, 2025 |
TENX |
Tenax Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
21.2% |
$5.81M |
|
968K |
|
Ikarian Capital, LLC |
Sep 30, 2025 |
AVTX |
Avalo Therapeutics, Inc. |
Common Stock, $0.001 Par Value |
9.99% |
$6.91M |
|
1.19M |
|
Ikarian Capital, LLC |
Mar 31, 2025 |
TRAW |
Traws Pharma, Inc. |
Common stock, par value $.01 per share |
9.99% |
$1.16M |
$385K |
590K |
+49.5% |
Ikarian Capital, LLC |
Mar 31, 2025 |
GRTX |
Galera Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
9.99% |
$377K |
|
7.54M |
|
Ikarian Capital, LLC |
Dec 31, 2024 |
AEMD |
Aethlon Medical, Inc. |
Common Stock, $0.001 par value per share |
8.7% |
$443K |
|
1.23M |
|
Ikarian Capital, LLC |
Dec 31, 2024 |
CHRO |
Channel Therapeutics Corp |
Common Stock, par value $0.0001 per share |
7.3% |
$595K |
|
441K |
|
Ikarian Capital, LLC |
Dec 31, 2024 |
ATXI |
Avenue Therapeutics, Inc. |
Common Stock |
6.8% |
$46.2K |
|
140K |
|
Ikarian Capital, LLC |
Dec 31, 2024 |
ACOG |
Alpha Cognition Inc. |
Common Shares, no par value |
6% |
$4.29M |
|
968K |
|
Ikarian Capital, LLC |
Dec 31, 2024 |
FBRX |
Forte Biosciences, Inc. |
Common Stock, $0.001 par value |
4.99% |
$7.06M |
$96.5K |
618K |
+1.39% |
Ikarian Capital, LLC |
Jun 30, 2025 |
CPIX |
Cumberland Pharmaceuticals Inc. |
Common Stock, no par value |
4.9% |
$3.09M |
|
731K |
|
Ikarian Capital, LLC |
Mar 31, 2025 |